scholarly journals What is the significance of end-stage renal disease risk estimation in living kidney donors?

2017 ◽  
Vol 30 (8) ◽  
pp. 799-806 ◽  
Author(s):  
François Gaillard ◽  
Stéphanie Baron ◽  
Marc-Olivier Timsit ◽  
Dominique Eladari ◽  
Catherine Fournier ◽  
...  
2018 ◽  
Vol 227 (4) ◽  
pp. S91
Author(s):  
Carrie Thiessen ◽  
Jacqueline Gannon ◽  
Daniel Gray ◽  
Kristie Kennedy ◽  
Danielle Dobosz ◽  
...  

2017 ◽  
Vol 91 (3) ◽  
pp. 699-703 ◽  
Author(s):  
Jayme E. Locke ◽  
Rhiannon D. Reed ◽  
Allan Massie ◽  
Paul A. MacLennan ◽  
Deirdre Sawinski ◽  
...  

2006 ◽  
Vol 38 (8) ◽  
pp. 2642-2643 ◽  
Author(s):  
I. Fehrman-Ekholm ◽  
G. Nordén ◽  
A. Lennerling ◽  
M. Rizell ◽  
H. Herlitz ◽  
...  

2017 ◽  
Vol 27 (1) ◽  
pp. 29-35
Author(s):  
WALTER GLANNON

Abstract:This article examines two questions. (1) If prospective living kidney donors knew of the lifetime risk of end-stage renal disease (ESRD) in their remaining kidney, then would they be as willing to give it up? and (2) What should transplant organizations and physicians be telling those who express an interest in donating a kidney about risk? Based on the principle that prospective donors must be fully informed of the risk, I raise the issue of a possible obstacle to closing the gap between the availability and need of transplantable kidneys. Some strategies are offered to address this problem.


JAMA Surgery ◽  
2020 ◽  
Vol 155 (3) ◽  
pp. e195472 ◽  
Author(s):  
Allan B. Massie ◽  
Courtenay M. Holscher ◽  
Macey L. Henderson ◽  
Lara M. Fahmy ◽  
Alvin G. Thomas ◽  
...  

2009 ◽  
Vol 9 (11) ◽  
pp. 2514-2519 ◽  
Author(s):  
R. Kido ◽  
Y. Shibagaki ◽  
K. Iwadoh ◽  
I. Nakajima ◽  
S. Fuchinoue ◽  
...  

2014 ◽  
Vol 23 (6) ◽  
pp. 592-596 ◽  
Author(s):  
Ngan N. Lam ◽  
Krista L. Lentine ◽  
Amit X. Garg

Sign in / Sign up

Export Citation Format

Share Document